Table 1. Gene usage of selected cross neutralizing scFv monoclonals.
| scFv ID | VH | DH | JH | CDRH3 | VL | JL | CDRL3 |
|---|---|---|---|---|---|---|---|
| D11 | IGHV5-51*01 | IGHD2-21*02 | IGHJ4*02 | CAKGLAYCGGDCYPYFDYW | IGLV6-57*01 | IGLJ3*02 | CQSYDSSNQVF |
| C11 | IGHV5-51*01 | IGHD4-11*01 | IGHJ5*02 | CARQGGNDYSLFDPW | IGLV3-1*01 | IGLJ1*01 | CRAWDTSTALYSF |
| 1F6 | IGHV1-46*01 | IGHD5*01 | IGHJ5*01 | CARAPRGYSYLDVW | IGLV2-14 | IGLJ1*01 | CSSYRSGRTQVF |
Heavy and light chain gene usage results of the selected scFv monoclonals. 3 scFv monoclonals D11, C11 and 1F6 were found to have different CDRH3 and gene usage.